How EU Cardiovascular Health Plan could transform health in Europe

Trade group the European Federation of Pharmaceutical Industries and Associations (EFPIA) welcomes the forthcoming EU Cardiovascular Health (CVH) Plan which will deliver much-needed political momentum for improving health in Europe.

The Plan should set out impactful, high-level targets and actions focused on reducing premature mortality and morbidity – developed and implemented with all stakeholders, including patients, healthcare professionals and industry.

1 in 3 deaths in the European Union (EU) are due to cardiovascular disease (CVD), with 20% of all premature deaths (before the age of 65) caused by cardiovascular conditions. In addition to the human suffering, cardiovascular disease is estimated to cost the European economy 282 billion euros ($330 billion) each year. Prevention, early detection, timely intervention and long-term, person-centred management are essential for improving health outcomes and quality of life for patients, as well as underpinning much needed economic prosperity for Europe.